SLC2A1 and metabolic dysfunction-associated steatotic liver disease: WB analysis confirmed that celastrol decreased the expression of glycolytic enzymes (i.e., GLUT1, PKM2) and the key signaling proteins (i.e., p-Akt, HIF1α) in liver of NAFLD mice (Figs. 7B-7C).